About PepGen Ltd
Ticker
info
PEPG
Trading on
info
NASDAQ
ISIN
info
US7133171055
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. James G. McArthur Ph.D.
Headquarters
info
321 Harrison Avenue, Boston, MA, United States, 02118
Employees
info
57
Website
info
https://pepgen.com
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$361M
P/E ratio
info
-
EPS
info
-$2.82
Dividend Yield
info
0.00%
Beta
info
1.96
Forward P/E ratio
info
0
EBIDTA
info
$-96.8M
Ex dividend date
info
-
Price & volume
Market cap
info
$361M
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
2.15
Earnings
EPS
info
-$2.82
EPS estimate (current quarter)
info
-$0.57
EPS estimate (next quarter)
info
-$0.50
EBITDA
info
$-96.8M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.96
52-week High
info
$6.72
52-week Low
info
$0.88
50-day moving average
info
$4.88
200-day moving average
info
$2.35
Short ratio
info
3.24
Short %
info
4.14%
Management effectiveness
ROE (TTM)
info
-62.25%
ROA (TTM)
info
-34.09%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
68.7M
Float
info
40.2M
Insiders %
info
0.13%
Institutions %
info
91.71%
Analyst Insights & forecasts
info

80% Buy

0% Hold

20% Sell

Based on information from 5 analysts.

Average price target

info
$10.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.68
-$0.81
16.05%
Q4 • 24Beat
-$0.92
-$0.72
-27.78%
Q1 • 25Missed
-$0.70
-$0.81
13.58%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-23.1M
-∞%
Q2 • 25
$0M
$-18M
-∞%
Q3 • 25
NaN%
-21.92%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$102M
$31.1M
30.40%
Q2 • 25
$190M
$26.9M
14.16%
Q3 • 25
85.89%
-13.41%
-53.42%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-23.6M
$15M
$0.1M
$-23.6M
Q2 • 25
$-19.3M
$18.9M
$108M
$-19.4M
Q3 • 25
-18.40%
26.38%
110,157.14%
-18.14%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a PepGen Ltd share?
Collapse

PepGen Ltd shares are currently traded for undefined per share.

How many shares does PepGen Ltd have?
Collapse

PepGen Ltd currently has 68.7M shares.

Does PepGen Ltd pay dividends?
Collapse

No, PepGen Ltd doesn't pay dividends.

What is PepGen Ltd 52 week high?
Collapse

PepGen Ltd 52 week high is $6.72.

What is PepGen Ltd 52 week low?
Collapse

PepGen Ltd 52 week low is $0.88.

What is the 200-day moving average of PepGen Ltd?
Collapse

PepGen Ltd 200-day moving average is $2.35.

Who is PepGen Ltd CEO?
Collapse

The CEO of PepGen Ltd is Dr. James G. McArthur Ph.D..

How many employees PepGen Ltd has?
Collapse

PepGen Ltd has 57 employees.

What is the market cap of PepGen Ltd?
Collapse

The market cap of PepGen Ltd is $361M.

What is the P/E of PepGen Ltd?
Collapse

The current P/E of PepGen Ltd is null.

What is the EPS of PepGen Ltd?
Collapse

The EPS of PepGen Ltd is -$2.82.

What is the PEG Ratio of PepGen Ltd?
Collapse

The PEG Ratio of PepGen Ltd is null.

What do analysts say about PepGen Ltd?
Collapse

According to the analysts PepGen Ltd is considered a buy.